Email this article Transport Platform Synthesis for Drug Development
- Authors: Stukalov Y.V.1, Grigor’eva E.Y.1, Kulakov V.N.2, Baryshnikov A.Y.1
-
Affiliations:
- N. N. Blokhin Russian Cancer Research Center
- A. I. Burnazyan Federal Medical Biophysics Center, Federal Medico-Biological Agency of Russia
- Issue: Vol 51, No 6 (2017)
- Pages: 480-481
- Section: Article
- URL: https://ogarev-online.ru/0091-150X/article/view/244661
- DOI: https://doi.org/10.1007/s11094-017-1637-9
- ID: 244661
Cite item
Open Access
Access granted
Subscription Access
Abstract
Asynthetic scheme for a transport platform for the creation of new diagnostic and therapeutic antitumor drugs that was based on a dendrimer with a core of pentaerythritol tetraglycidyl ether (TGEPE) and dendra with diallylamine was developed. The transport platform was promising for designing targeted antitumor agents for magnetic resonance tomography and nuclear medicine.
About the authors
Yu. V. Stukalov
N. N. Blokhin Russian Cancer Research Center
Email: chem@folium.ru
Russian Federation, 24 Kashirskoe Shosse, Moscow, 115478
E. Yu. Grigor’eva
N. N. Blokhin Russian Cancer Research Center
Email: chem@folium.ru
Russian Federation, 24 Kashirskoe Shosse, Moscow, 115478
V. N. Kulakov
A. I. Burnazyan Federal Medical Biophysics Center, Federal Medico-Biological Agency of Russia
Email: chem@folium.ru
Russian Federation, 46 Zhivopisnaya St, Moscow, 123182
A. Yu. Baryshnikov
N. N. Blokhin Russian Cancer Research Center
Email: chem@folium.ru
Russian Federation, 24 Kashirskoe Shosse, Moscow, 115478
Supplementary files
